bit bio
Our breakthrough technology combines synthetic and stem cell biology, offering limitless possibilities. Enabling a new generation of cell therapies, providing the best human cells for research and drug discovery, and allowing the control of advanced synthetic biology circuits for biomanufacturing.
Contact bit bio via their website
News archive
25/06/2021 bit.bio's Davide Danovi presented opti-ox™ at Sci Foo Camp...more
22/06/2021 bit.bio Founder and CEO Dr Mark Kotter featured on the Bioinformatics CRO Podcast ...more
18/06/2021 bit.bio Founder and CEO interview on the promise of stem cells in MoneyWeek...more
20/05/2021 bit.bio looks to transform dementia treatments and grow organs to order...more
14/05/2021 bit.bio's Mark Kotter: "A single cell to feed the world"...more
26/04/2021 Read bit.bio CEO blogpost on why he started a healthcare and cultured meat company...more
21/04/2021 bit.bio - Inside the breakthrough taking lab-grown meat to the supermarket...more
16/04/2021 bit.bio wins Biotech Company of the Year...more
14/04/2021 Meet the company reprogramming the future of synthetic biology...more
09/04/2021 Sitting down with... bit.bio...more
07/04/2021 Pint of Science podcast mini-series: why bit.bio is 'coding cells for health' ...more
26/03/2021 bit.bio CEO speaks at TEDxCambridgeUniversity event...more
23/03/2021 Cultivated meat, cell therapies and opti-ox™ - as told by bit bio...more
11/02/2021 bit.bio Welcomes New Chief Medical Officer Ramy Ibrahim...more
13/11/2020 bit.bio published in Forbes...more
27/10/2020 bit.bio published in The Times...more
27/10/2020 bit.bio on a moonshot mission with London Institute for Mathematical Sciences...more
11/06/2020 bit bio secures $41.5m funding from top life sciences investors...more
26/02/2020 bit bio Secures Distribution Agreement with Abcam...more
11/12/2019 Charles River Announces Strategic Partnership with bit bio...more
01/12/2019 bit bio joins the BioPartner programme...more
